ABBOTT LABORATORIES Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities
ABBOTT LABORATORIES (ABT) reported Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities of $144.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-21.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2025-02-21
- ABBOTT LABORATORIES unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2023 was $144.00M, a 4700.00% increase from fiscal 2022.
- ABBOTT LABORATORIES unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2022 was $3.00M.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2023-12-31 | $144.00M 10-K · filed 2025-02-21 |
| 2022-12-31 | $3.00M 10-K · filed 2024-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |